SCHEMBL6129396

SCHEMBL6129396

CCC(Cl)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9435763 0.83 KMT2A (0.37)
SCHEMBL4929498 0.80 HTT (0.39)
SCHEMBL9435754 0.79 HTT (0.35)
SCHEMBL2880798 0.77 ALOX5 (0.39)
SCHEMBL11552954 0.77 SLC6A2 (0.36)
SCHEMBL20213737 0.77 KMT2A (0.38)
SCHEMBL12311962 0.76
SCHEMBL94688 0.76
SCHEMBL827372 0.75 ALOX5 (0.35)
SCHEMBL5711552 0.75 KMT2A (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050084512-A1 Tridimensional biocompatible support structure for bioartificial organs and uses thereof TRANSFERT PLUS, SOCIETE EN COMMANDITE (CA) 2005-04-21 US disclosed
EP-1387885-A1 TRIDIMENSIONAL BIOCOMPATIBLE SUPPORT STRUCTURE FOR BIOARTIFICIAL ORGANS AND USES THEREOF UNIVERSITE DU QUEBEC A MONTREAL (CA) 2004-02-11 EP disclosed
WO-2002088331-A1 TRIDIMENSIONAL BIOCOMPATIBLE SUPPORT STRUCTURE FOR BIOARTIFICIAL ORGANS AND USES THEREOF UNIVERSITE DU QUEBEC A MONTREAL (CA) 2002-11-07 WO disclosed
EP-0874828-A4 COMPOSITION FOR TREATING PAIN LILLY CO ELI (US) 1999-09-01 EP disclosed
CN-1040979-C Antipsychotic method NOVO NORDISK AS (DK) 1998-12-02 CN disclosed
EP-0874828-A1 COMPOSITION FOR TREATING PAIN ELI LILLY AND COMPANY (US) 1998-11-04 EP disclosed
WO-1997020819-A1 COMPOSITION FOR TREATING PAIN ELI LILLY AND COMPANY (US) 1997-06-12 WO disclosed
WO-1997017962-A1 METHOD FOR TREATING ANXIETY ELI LILLY AND COMPANY (US) 1997-05-22 WO disclosed
US-5527813-A THERAPEUTICALLY ACTIVE AZABICYCLIC COMPOUNDS USEFUL AS STIMULANTS OF THE COGNITIVE FUNCTION OF THE FOREBRAIN AND IN THE TREATMENT OF ALZHEIMER'S DISEASE NOVO NORDISK A/S (DK) 1996-06-18 US disclosed
US-5338571-A Surface modification of substrates to provide covalent bonding with fullerenes NORTHWESTERN UNIVERSITY (US) 1994-08-16 US disclosed